Enzo Biochem Insiders

Enzo Biochem Management Team Effectiveness

The company has Return on Asset of (0.0746) % which means that on every $100 spent on assets, it lost $0.0746. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1295) %, meaning that it generated no profit with money invested by stockholders. Enzo Biochem's management efficiency ratios could be used to measure how well Enzo Biochem manages its routine affairs as well as how well it operates its assets and liabilities. Enzo Biochem holds a total of 52.4 Million outstanding shares. Enzo Biochem retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Enzo Biochem in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Enzo Biochem, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Enzo Biochem Workforce Comparison

The company has Net Profit Margin of (0.73) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.22) %, which entails that for every $100 of revenue, it lost $0.22.

Enzo Biochem Insider Trading

Enzo Biochem Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Enzo Biochem often depends on how effective the management is. Enzo Biochem management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Enzo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Enzo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Enzo Biochem's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Enzo Biochem. Check Enzo Biochem's Beneish M Score to see the likelihood of Enzo Biochem's management manipulating its earnings.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

If you are still planning to invest in Enzo Biochem check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzo Biochem's history and understand the potential risks before investing.